Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stirling

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Neural Regeneration Research|October 7, 2022
Potential physiological and pathological roles for axonal ryanodine receptorsDavid P Stirling
Journal of General Microbiology|May 1, 1977
The developmental cycle of Chlamydia trachomatis in McCoy cells treated with cytochalasin BP Stirling, S Richmond
Infection and Immunity|November 1, 1981
Localization of chlamydial group Antigen in McCoy cell monolayers infected with Chlamydia trachomatis or Chlamydia psittaciS J Richmond, P Stirling
Trends in Molecular Medicine|March 9, 2010
Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulationDavid P Stirling, Peter K Stys
Journal of Neuroscience Research|April 29, 2008
Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometryDavid P Stirling, V Wee Yong
Journal of Neurotrauma|December 16, 2021
Inhibiting Calcium Release from Ryanodine Receptors Protects Axons after Spinal Cord InjuryBen C Orem, Arezoo Rajaee, David P Stirling
Neurobiology of Disease|October 4, 2020
IP<sub>3</sub>R-mediated intra-axonal Ca<sup>2+</sup> release contributes to secondary axonal degeneration following contusive spinal cord injuryBen C Orem, Arezoo Rajaee, David P Stirling
Neurobiology of Disease|December 18, 2019
Inhibiting store-operated calcium entry attenuates white matter secondary degeneration following SCIBen C Orem, Steven B Partain, David P Stirling
Experimental Neurology|July 15, 2014
Immune modulatory therapies for spinal cord injury--past, present and futureJason R Plemel, V Wee Yong, David P Stirling
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Targeting MMPs in acute and chronic neurological conditionsV Wee Yong, Smriti M Agrawal, David P Stirling
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Neural Regeneration Research|October 7, 2022
Potential physiological and pathological roles for axonal ryanodine receptorsDavid P Stirling
Journal of General Microbiology|May 1, 1977
The developmental cycle of Chlamydia trachomatis in McCoy cells treated with cytochalasin BP Stirling, S Richmond
Infection and Immunity|November 1, 1981
Localization of chlamydial group Antigen in McCoy cell monolayers infected with Chlamydia trachomatis or Chlamydia psittaciS J Richmond, P Stirling
Trends in Molecular Medicine|March 9, 2010
Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulationDavid P Stirling, Peter K Stys
Journal of Neuroscience Research|April 29, 2008
Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometryDavid P Stirling, V Wee Yong
Journal of Neurotrauma|December 16, 2021
Inhibiting Calcium Release from Ryanodine Receptors Protects Axons after Spinal Cord InjuryBen C Orem, Arezoo Rajaee, David P Stirling
Neurobiology of Disease|October 4, 2020
IP<sub>3</sub>R-mediated intra-axonal Ca<sup>2+</sup> release contributes to secondary axonal degeneration following contusive spinal cord injuryBen C Orem, Arezoo Rajaee, David P Stirling
Neurobiology of Disease|December 18, 2019
Inhibiting store-operated calcium entry attenuates white matter secondary degeneration following SCIBen C Orem, Steven B Partain, David P Stirling
Experimental Neurology|July 15, 2014
Immune modulatory therapies for spinal cord injury--past, present and futureJason R Plemel, V Wee Yong, David P Stirling
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Targeting MMPs in acute and chronic neurological conditionsV Wee Yong, Smriti M Agrawal, David P Stirling
Pageof 4